YNIOS Pharma
ActiveSummary
The computed 12-month bankruptcy probability of YNIOS Pharma is 3.1% (moderate). The 2025 annual accounts show equity of €473,563 and a net result of -€228,903. Equity is growing by about 61% per year across the filed financial years. Its solvency ranks better than 72% of 146 sector peers (NACE 20, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 24 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 25050F0026/00P017 | Wallonia | 1,390 m² | 1 · 394 m² | 14.5 m · 3 |